Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
BMC Cancer|July 18, 2018
The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysisJi-Jin Yao, Ya-Nan Jin, Si-Yang Wang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2018
Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysisJi-Jin Yao, Fan Zhang, Tian-Sheng Gao, et al.Chinese Journal of Cancer|August 13, 2015
Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization systemLu-Jun Shen, Si-Yang Wang, Guo-Feng Xie, et al.Cancer Biology & Therapy|August 8, 2018
Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinomaJi-Jin Yao, Lu-Lu Zhang, Tian-Sheng Gao, et al.Therapeutics and Clinical Risk Management|August 14, 2018
The characteristics and risk factors for cisplatin-induced acute kidney injury in the elderlyJie-Qiong Liu, Guang-Yan Cai, Si-Yang Wang, et al.Cancer Immunology, Immunotherapy : CII|May 11, 2024
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysisYa-Nan Jin, Meng-Yun Qiang, Ying Wang, et al.BMC Nephrology|February 15, 2017
Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysisYu-Huan Song, Guang-Yan Cai, Yue-Fei Xiao, et al.Cancer Research and Treatment|February 8, 2018
The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy EraYa-Nan Jin, Wang-Jian Zhang, Xiu-Yu Cai, et al.Drug Design, Development and Therapy|August 26, 2014
Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysisPei-Jian Peng, Hua Cheng, Xue-Qing Ou, et al.Journal of Cancer|May 23, 2015
Significant prognostic impact of chemoradiotherapy-induced hemoglobin decrease on treatment outcomes of nasopharyngeal carcinomaXue-Xia Liang, Qun Li, Zhen Su, et al.Pageof 7